1-10 of 10
Catherine D. Williams
Close
Sort by
Journal Articles

Final Analysis From the International Trial of Single-Agent Ofatumumab In Patients with Fludarabine-Refractory Chronic Lymphocytic Leukemia

William G. Wierda, MD, PhD, Thomas J. Kipps, MD, PhD, Jiri Mayer, MD, PhD, Tadeusz Robak, MD, PhD, Martin JS Dyer, MA, DPhil, FRCP, FRCPath, Richard R. Furman, MD, Peter Hillmen, MBChB, FRCP, FRCPath, PhD, Stephan Stilgenbauer, M.D., Catherine D. Williams, FRCPath, Marek Trneny, MD, PhD, Guillaume Cartron, MD, PhD, Francisco J. Hernandez-Ilizaliturri, MD, Swaminathan Padmanabhan, MBBS, MS, Geoffrey W. Chan, MD, Ira V. Gupta, MD, Michele M. Gorczyca, MS, Randy L. Davis, DrPH, Nedjad Losic, MSc, Steen Lisby, MD, DMSC, Anders Österborg, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 921.
https://doi.org/10.1182/blood.V116.21.921.921
Published: 2010
Journal Articles

Determinants of Global QOL and Physical and Social Functionality In Multiple Myeloma

Karin Jordan, PhD, K. Jack Ishak, PhD, Philip Lewis, PhD, Irina Proskorovsky, MSc, Krista A Payne, M.Ed, Noreen Lordan, BSc, Charalampia Kyriakou, MD, PhD, Faith Davies, Sarah Peters, Catherine D Williams, MD
Journal: Blood
Blood (2010) 116 (21): 934.
https://doi.org/10.1182/blood.V116.21.934.934
Published: 2010
Journal Articles

Components of Global Quality of Life In Multiple Myeloma

Catherine D Williams, MD, Irina Proskorovsky, MSc, Philip Lewis, PhD, K. Jack Ishak, PhD, Krista A Payne, M.Ed, Noreen Lordan, BSc, Charalampia Kyriakou, MD, PhD, Faith Davies, MD, Sarah Peters, Karin Jordan, PhD
Journal: Blood
Blood (2010) 116 (21): 4735.
https://doi.org/10.1182/blood.V116.21.4735.4735
Published: 2010
Journal Articles

Ofatumumab (HuMax-CD20), a Novel CD20 Monoclonal Antibody, Is An Active Treatment for Patients with CLL Refractory to Both Fludarabine and Alemtuzumab or Bulky Fludarabine-Refractory Disease: Results from the Planned Interim Analysis of An International Pivotal Trial

Anders Osterborg, MD, PhD, Thomas J. Kipps, MD, PhD, Jiri Mayer, MD, Stephan Stilgenbauer, Dr.med, Catherine D Williams, MBBS, MRCP, FRCPath, Andrzej Hellmen, MD, PhD, Tadeusz Robak, MD, PhD, Richard R Furman, MD, Peter Hillmen, MBChB, PhD, Marek Trneny, MD, PhD, Martin J.S. Dyer, MA, DPhil, FRCP, Swaminathan Padmanabhan, MD, MBBS, Tomas Kozak, MD, PhD, Geoffrey Chan, MD, Randy L Davis, DrPH, Nedjad Losic, MSc, Charlotte A. Russell, MD, DMSC, Magdalena Piotrowska, MD, Joris Wilms, MSc., Pharm, William G. Wierda, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 328.
https://doi.org/10.1182/blood.V112.11.328.328
Published: 2008
Journal Articles

Combination Chemotherapy with Cyclophosphamide, Thalidomide and Dexamethasone Achieves a High Response Rate in Patients with Newly Diagnosed, VAD-Refractory and Relapsed Myeloma.

Catherine D. Williams, MD, Jennifer L. Byrne, MD, PhD, Gamal Sidra, MD, Sonya Zaman, MD, Nigel H. Russell, MD
Journal: Blood
Blood (2004) 104 (11): 1499.
https://doi.org/10.1182/blood.V104.11.1499.1499
Published: 2004
Journal Articles

The toxicity and efficacy of donor lymphocyte infusions given after reduced-intensity conditioning allogeneic stem cell transplantation

Clinical Trials & Observations
David I. Marks, Richard Lush, Jamie Cavenagh, Donald W. Milligan, Steven Schey, Anne Parker, Fiona J. Clark, Linda Hunt, John Yin, Steven Fuller, Elisabeth Vandenberghe, Judith Marsh, Timothy Littlewood, Graeme M. Smith, Dominic Culligan, Ann Hunter, Rajesh Chopra, Andrew Davies, Keiren Towlson, Catherine D. Williams
Journal: Blood
Blood (2002) 100 (9): 3108–3114.
https://doi.org/10.1182/blood-2002-02-0506
Published: 2002
Journal Articles

Limiting transplantation-related mortality following unrelated donor stem cell transplantation by using a nonmyeloablative conditioning regimen

Ronjon Chakraverty, Karl Peggs, Rajesh Chopra, Donald W. Milligan, Panagiotis D. Kottaridis, Stephanie Verfuerth, Johanne Geary, Dharsha Thuraisundaram, Kate Branson, Suparno Chakrabarti, Premini Mahendra, Charles Craddock, Anne Parker, Ann Hunter, Geoff Hale, Herman Waldmann, Catherine D. Williams, Kwee Yong, David C. Linch, Anthony H. Goldstone, Stephen Mackinnon
Journal: Blood
Blood (2002) 99 (3): 1071–1078.
https://doi.org/10.1182/blood.V99.3.1071
Published: 2002
Journal Articles

In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation

Clinical Trials & Observations
Panagiotis D. Kottaridis, Donald W. Milligan, Rajesh Chopra, Ronjon K. Chakraverty, Suparno Chakrabarti, Stephen Robinson, Karl Peggs, Stephanie Verfuerth, Ruth Pettengell, Judith C. W. Marsh, Stephen Schey, Premini Mahendra, Gareth J. Morgan, Geoff Hale, Herman Waldmann, M. Carmen Ruiz de Elvira, Catherine D. Williams, Stephen Devereux, David C. Linch, Anthony H. Goldstone, Stephen Mackinnon
Journal: Blood
Blood (2000) 96 (7): 2419–2425.
https://doi.org/10.1182/blood.V96.7.2419
Published: 2000
Journal Articles

Cytomegalovirus infection and disease after autologous CD34-selected peripheral blood stem cell transplantation for multiple myeloma: no evidence of increased incidence based on polymerase-chain-reaction monitoring

Karl S. Peggs, Stuart J. Ings, Panagiotis D. Kottaridis, Kwee Yong, Catherine D. Williams, Anthony H. Goldstone, Stephen Mackinnon
Journal: Blood
Blood (2000) 96 (1): 369–371.
https://doi.org/10.1182/blood.V96.1.369
Published: 2000
Journal Articles

Characterization of Cell Cycle Status and E2F Complexes in Mobilized CD34 + Cells Before and After Cytokine Stimulation

Catherine D. Williams, David C. Linch, Mike J. Watts, N. Shaun B. Thomas
Journal: Blood
Blood (1997) 90 (1): 194–203.
https://doi.org/10.1182/blood.V90.1.194
Published: 1997